Shah PM - Search Results

1

Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

Groll AH, Just-Nuebling G, Kurz M, Mueller C, Nowak-Goettl U, Schwabe D, Shah PM, Kornhuber B. Groll AH, et al. Among authors: shah pm. J Antimicrob Chemother. 1997 Dec;40(6):855-62. doi: 10.1093/jac/40.6.855. J Antimicrob Chemother. 1997. PMID: 9462438 Clinical Trial.

2

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital.

Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Groll AH, et al. Among authors: shah pm. J Infect. 1996 Jul;33(1):23-32. doi: 10.1016/s0163-4453(96)92700-0. J Infect. 1996. PMID: 8842991

3

Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.

Böhme A, Just-Nübling G, Bergmann L, Shah PM, Stille W, Hoelzer D. Böhme A, et al. Among authors: shah pm. J Antimicrob Chemother. 1996 Dec;38(6):953-61. doi: 10.1093/jac/38.6.953. J Antimicrob Chemother. 1996. PMID: 9023642 Clinical Trial.

4

Influence of cefpirome on pharyngeal and faecal flora after single and multiple intravenous administrations of cefpirome to healthy volunteers.

Knothe H, Schäfer V, Sammann A, Badian M, Shah PM. Knothe H, et al. Among authors: shah pm. J Antimicrob Chemother. 1992 Apr;29 Suppl A:81-6. doi: 10.1093/jac/29.suppl_a.81. J Antimicrob Chemother. 1992. PMID: 1601763

5

[Teichoic acid antibody assay in infections of the bones and joints caused by Staphylococcus aureus].

Groll A, Shah PM. Groll A, et al. Among authors: shah pm. Unfallchirurg. 1989 Aug;92(8):414-8. Unfallchirurg. 1989. PMID: 2508226 German.

6

Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.

Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R. Shah PM, et al. J Antimicrob Chemother. 1999 Apr;43(4):529-39. doi: 10.1093/jac/43.4.529. J Antimicrob Chemother. 1999. PMID: 10350383 Clinical Trial.

7

Fleroxacin: safety, tolerance and effect on the faecal flora of healthy volunteers.

Shah PM, Sammann A, Schäfer V, Seczendi M, Knothe H. Shah PM, et al. J Antimicrob Chemother. 1988 Oct;22 Suppl D:209-13. doi: 10.1093/jac/22.supplement_d.209. J Antimicrob Chemother. 1988. PMID: 3144539

8

Comparison of clinical response to cefpirome treatment and minimum inhibitory concentration of causative isolates. Microbiological and Clinical Study Groups.

Shah PM, Schäfer V, Ziemen M, Krauskopf S. Shah PM, et al. J Antimicrob Chemother. 1992 Apr;29 Suppl A:75-80. doi: 10.1093/jac/29.suppl_a.75. J Antimicrob Chemother. 1992. PMID: 1601762

9

In-vitro activity of cefpirome against isolates from patients with urinary tract, lower respiratory tract and wound infections.

Schäfer V, Shah PM, Doerr HW, Ziemen M, Hellwich S, Seibert G. Schäfer V, et al. Among authors: shah pm. J Antimicrob Chemother. 1992 Apr;29 Suppl A:7-12. doi: 10.1093/jac/29.suppl_a.7. J Antimicrob Chemother. 1992. PMID: 1601760

10

Prospective randomized study to compare imipenem 1.5 grams per day vs. 3.0 grams per day in infections of granulocytopenic patients.

Böhme A, Shah PM, Stille W, Hoelzer D. Böhme A, et al. Among authors: shah pm. J Infect. 1998 Jan;36(1):35-42. doi: 10.1016/s0163-4453(98)93018-3. J Infect. 1998. PMID: 9515666 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

727 results

Search Page

Filters